The Fatigue Rotarod segmentation by application isolates five principal use‑cases that collectively drive market volume. Neuroscience research (≈35 %) dominates, as investigators quantify motor coordination deficits in models of Parkinson’s, Alzheimer’s, and stroke, directly influencing demand for high‑throughput devices. Pharmacological testing (≈30 %) follows, where drug candidates are screened for neuromuscular side effects, requiring precise, repeatable protocols that elevate equipment turnover. Toxicology screening (≈20 %) contributes by assessing acute and chronic exposure impacts on motor endurance, a regulatory mandate for many chemical safety programs. Genetic studies (≈10 %) leverage the rotarod to phenotype knockout or transgenic lines, a niche yet growth‑oriented segment tied to expanding CRISPR applications. Finally, behavioral phenotyping (≈5 %) supports broader ethological investigations, often as a supplemental assay in multidisciplinary labs. Each application’s distinct methodological needs shape pricing tiers, service contracts, and accessory sales, cumulatively defining the overall Fatigue Rotarod market size.